Megha Katti
Enthusiast · DISC type iMegha Katti heads Business Intelligence and Analytics for the Rare Portfolio at Apellis Pharmaceuticals. An MBA from Harvard Business School, she specializes in commercial insights and strategic forecasting for rare diseases, with prior leadership roles at Sarepta Therapeutics and Alnylam Pharmaceuticals.
She has deep experience leading commercial opportunity assessments and developing revenue forecasts for multiple pipeline products to guide company investment decisions.
Read the full overview →How Megha shows up
They are generally friendly, so be careful when relying on their word. Unlike D or C types, they are convinced more by stories and testimonials. They are more about building relationships than just cutting deals.
Topics Megha cares about
Work history
Media appearances
DISC profile (public)
Influence (I)
Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.
Other Apellis Pharmaceuticals Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.